Surgery Partners, Inc.
SGRY· Nasdaq
SGRYSurgery Partners, Inc.
Filed Mar 1, 2023 · 10-K · 60 days after period end · 0001638833-23-000021
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $707.10M | $610.20M | $548.30M | $517.20M |
| Net Income | -$23.40M | -$100.00K | $5.50M | -$19.20M |
| EPS Diluted | — | — |
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
| — |
| -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Mar 1, 2023 · 60 d after period end
